CHICAGO/ TAMPA, Fla., Aug 26- The U.S. Food and Drug Administration recommended on Friday that all blood donated in the United States and its territories be tested for Zika virus, as it moves to prevent transmission of the virus through the blood supply. The agency said its decision to expand blood screening in the United States was based on concerns about more cases...
Linette Lopez, Business Insider Senior Finance Editor, explains how further price hikes on the EpiPen could make a lot of money for Mylan CEO Heather Bresch. CNBC's Meg Tirrell weighs in.
Things like Mylan's EpiPen price hikes will keep happening unless these changes are made, former Vermont Gov. Howard Dean says.
David Martin, M-CAM Founder, discusses the EpiPen pricing saga and his view that the patent office gave Mylan an unjustified monopoly on the drug.
CHICAGO, Aug 26- The U.S. Food and Drug Administration recommended on Friday that all blood donated in the United States and its territories be tested for Zika virus, as it moves to prevent transmission of the virus through the blood supply. The agency said its move to expand blood screening in the United States was based on concerns about increasing cases of local...
Amid the Mylan EpiPen pricing saga, should there be greater regulation on the pharmaceuticals industry? Former Vermont Governor Howard Dean and CNBC Senior Contributor Larry Kudlow debate the issue.
*Puerto Rico reports 10 cases of Guillain-Barre related to Zika. Separately, health officials in Puerto Rico have reported as many as 10 people who developed the paralyzing neurological disorder known as Guillain-Barre syndrome as a result of Zika infections. In Puerto Rico, where Zika arrived in December 2015, health officials have been systematically...
WASHINGTON— The government told all U.S. blood banks Friday to start screening for Zika, a major expansion intended to protect the nation's blood supply from the mosquito-borne virus. Previously, blood testing was mostly limited to parts of Florida and Puerto Rico, where Zika is spreading. Peter Marks said in a Food and Drug Administration release.
If Mylan's CEO wants to lower the price of the EpiPen today, she could, Express Scripts' Dr. Steve Miller says.
Rep. Lloyd Doggett (D-Texas) discusses the EpiPen pricing saga and his views on greater price gouging in the drug industry with the "Fast Money" traders.
Amid the Mylan EpiPen pricing saga, CNBC's Meg Tirrell looks at the drugs that may be next in line for controversial price hikes.
Sen. Amy Klobuchar (D-Minn.) discusses the call for the FTC to investigate Mylan and other "bad actors" over drug pricing rules.
Sen. Amy Klobuchar (D-Minn.) discusses legislation for EpiPen-like generic drugs to be more widely available, pricing controls and drug importation from Canada.
Sen. Amy Klobuchar (D-Minn.) discusses Mylan CEO Heather Bresch's comments on the EpiPen pricing controversy.
Steve Miller, Express Scripts chief medical officer, responds to Mylan's CEO Heather Bresch blaming the "middle men" for higher drug prices.
To blame the healthcare system is what Mylan CEO Heather Bresch told CNBC today in explaining why the price of her company's EpiPen has seen price hikes of 400%. CNBC's Meg Tirrell breaks down the pharma supply chain system.
There needs to be more transparency in drug pricing, and Mylan still has a lot of questions to answer, Sen. Charles Grassley said Thursday.
CNBC's Meg Tirrell reports on the Pharmaceutical Care Management Association's response to Mylan blaming "the middlemen" for its EpiPen price hike.
Sen. Charles Grassley (R-Iowa), shares his take on Congress, drug price control and the prohibition on importing drugs.
Sen. Charles Grassley (R-Iowa), reacts to what Mylan CEO Heather Bresch had to say about the EpiPen pricing outrage.